Accellacare US Inc., d/b/a Accellacare of Knoxville

Knoxville, Tennessee 37938

0 studies enrolling now · 5 studies all time

What they study most

COVID-19, Diabetes Mellitus, Type 2, Influenza, Human, Lower Respiratory Tract Illness, Obesity, SARS-COV-2 Infection

Studies at this site

• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) — Completed
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed